Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NFκB Pathway in Human Non-small Cell Lung Cancer (vol 17, pg 1839, 2011)

被引：1
|
作者：
Song, Libing
Xiong, Huaping
Li, Jun
Liao, Wenting
Wang, Lan
Wu, Jueheng
Li, Mengfeng
机构：
来源：
CLINICAL CANCER RESEARCH | 2022年 / 28卷 / 08期
关键词：
D O I：
10.1158/1078-0432.CCR-22-0506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1740 / 1740
页数：1
相关论文
共 50 条
  • [31] Potential chemotherapeutic effect of betalain against human non-small cell lung cancer through PI3K/Akt/mTOR signaling pathway
    Yin, Zongxiu
    Yang, Yanna
    Guo, Tianfang
    Veeraraghavan, Vishnu Priya
    Wang, Xin
    ENVIRONMENTAL TOXICOLOGY, 2021, 36 (06) : 1011 - 1020
  • [32] NRSN2 promotes non-small cell lung cancer cell growth through PI3K/Akt/mTOR pathway
    Zhang, Xin-Yi
    Kuang, Jiu-Long
    Yan, Chun-Song
    Tu, Xiao-Yun
    Zhao, Ji-Hua
    Cheng, Xiao-Shu
    Ye, Xiao-Qun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (03): : 2574 - 2581
  • [33] Activation of PI3K/Akt pathway by G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer
    Liu, Han
    Zhu, Yingjie
    Niu, Huikun
    Jie, Jing
    Hua, Shucheng
    Bai, Xiaoxue
    Wang, Shuai
    Song, Lei
    CANCER MEDICINE, 2023, 12 (19): : 19777 - 19793
  • [34] CNPY2 enhances resistance to apoptosis induced by cisplatin via activation of NF-κB pathway in human non-small cell lung cancer
    Dou, Yu
    Yu, Qin
    Lei, Jun-qiang
    Guo, Shun-lin
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 1658 - 1663
  • [35] Anticancer Effects of Paris Saponins by Apoptosis and PI3K/AKT Pathway in Gefitinib-Resistant Non-Small Cell Lung Cancer
    Zhu, Xinhai
    Jiang, Hao
    Li, Jinhui
    Xu, Ji
    Fei, Zhenghua
    MEDICAL SCIENCE MONITOR, 2016, 22 : 1435 - 1441
  • [36] Polyphyllin I reverses the resistance of osimertinib in non-small cell lung cancer cell through regulation of PI3K/Akt signaling
    Lai, Lei
    Shen, Qiuping
    Wang, Yingjie
    Chen, Liting
    Lai, Jianjun
    Wu, Zhibing
    Jiang, Hao
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 419
  • [37] The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway
    Papoff, Giuliana
    Presutti, Dario
    Fustaino, Valentina
    Parente, Andrea
    Calandriello, Clelia
    Alema, Stefano
    Scavizzi, Ferdinando
    Raspa, Marcello
    Merlino, Giuseppe
    Salerno, Massimiliano
    Bigioni, Mario
    Binaschi, Monica
    Ruberti, Giovina
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] LncRNA TBX5-AS1 Regulates the Tumor Progression Through the PI3K/AKT Pathway in Non-Small Cell Lung Cancer
    Qu, Qing-hai
    Jiang, Shui-zheng
    Li, Xin-ying
    ONCOTARGETS AND THERAPY, 2020, 13 : 7949 - 7961
  • [39] Clinicopathological significance of PTEN and PI3K/AKT signal transduction pathway in non-small cell lung cancer
    Yun, Fen
    Jia, Yongfeng
    Li, Xiuxia
    Yuan, Li
    Sun, Qinnuan
    Yu, Huiling
    Shi, Lin
    Yuan, Hongwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (10): : 2112 - 2120
  • [40] miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway
    Yang, Wu
    Xiao, Wei
    Cai, Zhengrong
    Jin, Shidai
    Li, Tian
    ONCOTARGETS AND THERAPY, 2020, 13 : 109 - 118
12345